Viewing Study NCT06239194


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-01-07 @ 9:48 AM
Study NCT ID: NCT06239194
Status: RECRUITING
Last Update Posted: 2025-06-22
First Post: 2024-01-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Sponsor: ModeX Therapeutics, An OPKO Health Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module